CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 8-K Event Results of operations
- D/A Other Amended Notice of Exempt Offering of Securities
- 8-K Event Material agreement · Delisting notice · Unregistered share sale
- 8-K Event Other events
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Agreement ended · Results of operations · Exit or restructuring costs
- 8-K Event Executive or director change
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Shareholder vote results
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
Page 25 of 41 · 819 filings